TokenPost·
GSK’s Clinical-Stage Oncology Portfolio Could Nearly Double in 2027
Oncology chief Hesham Abdullah said GSK could have 19 to 20 late-stage studies underway that year. He put the current portfolio at about 15 assets.
More news
- TokenPostSimplismart CEO Says U.S. Accounts for About 55% of Revenue as Nvidia Joins Funding Round
- TokenPostJason Calacanis Sees Bitcoin Retesting $57,000 Within 12 Months
- TokenPostBlackRock ETHA and ETHB ETF Wallets Send About $105 Million in Ether to Coinbase Prime
- TokenPostTaraxa Rises 13.51% in 30 Minutes While Still Down 8.01% Over 24 Hours
- TokenPostBlackRock ETF Wallets Move $104.76 Million in Ether to Coinbase Prime
- Crypto BriefingStellar’s tokenized RWAs top $4.1 billion, but almost none of it is put to work in DeFi